Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.
Rezaieyazdi Z, Farooqi A, Soleymani-Salehabadi H, Ahmadzadeh A, Aslani M, Omidian S, Sadoughi A, Vahidi Z, Khodashahi M, Zamurrad S, Mortazavi-Jahromi SS, Fallahzadeh H, Hosseini M, Aghazadeh Z, Ekhtiari P, Matsuo H, Rehm BHA, Cuzzocrea S, D'Aniello A, Mirshafiey A. Rezaieyazdi Z, et al. Among authors: aslani m. Inflammopharmacology. 2019 Oct;27(5):911-921. doi: 10.1007/s10787-018-00557-2. Epub 2019 Jan 2. Inflammopharmacology. 2019. PMID: 30604197 Clinical Trial.
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
Mortazavi-Jahromi SS, Aslani M, Omidian S, Ahmadzadeh A, Rezaieyazdi Z, Mirshafiey A. Mortazavi-Jahromi SS, et al. Among authors: aslani m. Drug Dev Res. 2020 May;81(3):295-304. doi: 10.1002/ddr.21619. Epub 2019 Nov 1. Drug Dev Res. 2020. PMID: 31675124 Clinical Trial.
Mannuronic Acid in Low-Risk and Intermediate-1-Risk Myelodysplastic Syndromes.
Ghaderi A, Nodehi SRS, Bakhtiari T, Aslani M, Aghazadeh Z, Matsuo H, Rehm BHA, Cuzzocrea S, Mirshafiey A. Ghaderi A, et al. Among authors: aslani m. J Clin Pharmacol. 2020 Jul;60(7):879-888. doi: 10.1002/jcph.1587. Epub 2020 Feb 16. J Clin Pharmacol. 2020. PMID: 32064621 Clinical Trial.
The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS, Ahmadzadeh A, Rezaieyazdi Z, Aslani M, Omidian S, Mirshafiey A. Mortazavi-Jahromi SS, et al. Among authors: aslani m. Immunopharmacol Immunotoxicol. 2020 Jun;42(3):228-236. doi: 10.1080/08923973.2020.1742734. Epub 2020 Mar 29. Immunopharmacol Immunotoxicol. 2020. PMID: 32223462 Clinical Trial.
206 results